Silexion Therapeutics Corp
SLXN9.040USD
-0.240-2.59%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
9.040USD+9.040After-hours (ET)
78.58MMarket Cap
9.50P/E TTM
Silexion Therapeutics Corp
9.040
-0.240-2.59%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-40.01%-2.45M
-132.78%-2.93M
-287.30%-2.65M
36.46%-1.06M
-92.32%-1.75M
-290.37%-1.26M
-293.20%-685.00K
-2796.85%-1.68M
-548.13%-911.00K
--660.30K
--354.55K
---57.86K
---140.56K
Net income from continuing operations
-21.93%-1.73M
-3.99%-1.75M
-1366.01%-11.86M
20.63%-1.49M
-91.52%-1.42M
-439.80%-1.68M
-376.51%-809.00K
-4494.16%-1.88M
-202.45%-743.00K
--494.41K
--292.58K
--42.69K
---245.66K
Operating gains losses
-50.00%4.00K
----
120.00%22.00K
-50.00%7.00K
-46.67%8.00K
--6.00K
--10.00K
--14.00K
--15.00K
----
----
----
----
Other non-cash items
----
--4.77M
--68.00K
----
----
----
--0.00
----
----
----
----
----
----
Change in working capital
-63.17%-824.00K
-320.23%-947.00K
-1620.00%-430.00K
343.55%302.00K
-160.31%-505.00K
176.54%430.00K
-134.95%-25.00K
-93.14%-124.00K
-196.86%-194.00K
--155.49K
--71.53K
---64.20K
--200.29K
-Change in receivables
109.09%4.00K
1866.67%59.00K
-170.83%-17.00K
110.00%2.00K
-500.00%-44.00K
--3.00K
--24.00K
---20.00K
--11.00K
----
----
----
----
-Change in prepaid expenses
-296.90%-512.00K
82.95%-22.00K
-110.61%-417.00K
-1360.00%-63.00K
-1742.86%-129.00K
-258.77%-129.00K
-343.69%-198.00K
-93.85%5.00K
-108.62%-7.00K
--81.25K
--81.25K
--81.25K
--81.25K
-Change in payables and accrued expense
----
---1.90M
----
1034.29%327.00K
----
----
----
---35.00K
----
----
----
----
----
-Change in other current assets
----
---38.00K
----
----
----
----
----
----
----
----
----
----
----
-Change in other current liabilities
----
----
----
--0.00
-166.67%-20.00K
--20.00K
---30.00K
100.00%0.00
0.00%30.00K
----
--0.00
---30.00K
--30.00K
Cash from non-recurring investing activities
Cash from operating activities
-40.01%-2.45M
-132.78%-2.93M
-287.30%-2.65M
36.46%-1.06M
-92.32%-1.75M
-290.37%-1.26M
-293.20%-685.00K
-2796.85%-1.68M
-548.13%-911.00K
--660.30K
--354.55K
---57.86K
---140.56K
Investing cash flow
Net cash from continuing investing activities
0.00%6.00K
-100.00%0.00
122.22%16.00K
-100.00%0.00
--6.00K
--4.00K
---72.00K
--2.00K
--0.00
----
----
----
----
Capital expenditures
0.00%6.00K
-100.00%0.00
166.67%16.00K
-100.00%0.00
--6.00K
--4.00K
--6.00K
--2.00K
--0.00
----
----
----
----
Net cash flow from disposal of fixed assets
0.00%6.00K
-100.00%0.00
122.22%16.00K
-100.00%0.00
--6.00K
--4.00K
---72.00K
--2.00K
--0.00
----
----
----
----
Net cash flow from business transactions
----
----
--2.30M
----
----
----
----
----
----
----
----
----
----
Net cash flow from investment products
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--507.00K
----
----
----
----
Net cash flow from other investing activities
----
----
---2.30M
----
----
----
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
0.00%-6.00K
100.00%0.00
-122.22%-16.00K
100.00%0.00
-101.18%-6.00K
---4.00K
--72.00K
---2.00K
--507.00K
----
----
----
----
Financing cash flow
Cash flow from continuous financing activities
--7.43M
--2.18M
--2.92M
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00
770.00%522.00K
-100.00%0.00
--190.00K
--350.00K
--60.00K
--290.00K
Net cash flow from debt Issuance/repayment
-353.09%-696.00K
-171.43%-250.00K
----
-57.01%230.00K
-28.57%275.00K
84.21%350.00K
8.86%381.00K
791.67%535.00K
32.76%385.00K
--190.00K
--350.00K
--60.00K
--290.00K
Net cash flow from common stock issuance/repurchase
--5.00M
--2.43M
--620.00K
--0.00
100.00%0.00
--0.00
--0.00
--0.00
---90.75M
--0.00
--0.00
--0.00
--0.00
Net cash flow from preferred stock issuance/repurchase
----
----
--0.00
----
----
----
----
----
----
----
----
----
----
Proceeds from stock option exercised by employees
--0.00
----
--620.00K
----
----
----
----
----
----
----
----
----
----
Proceeds from issuance of warrants
--4.14M
----
----
----
----
----
----
----
----
----
----
----
----
Net cash flow from other financing activities
---1.01M
--0.00
--2.30M
----
----
----
--0.00
----
----
--0.00
--0.00
--0.00
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
--7.43M
--2.18M
--2.92M
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00
770.00%522.00K
-100.00%0.00
--190.00K
--350.00K
--60.00K
--290.00K
Net cash flow
Beginning cash balance
-72.66%1.27M
-65.19%2.02M
-73.09%1.75M
-64.27%2.83M
-44.10%4.64M
-94.99%5.81M
-94.37%6.49M
-93.12%7.92M
-92.78%8.31M
--115.90M
--115.20M
--115.19M
--115.05M
Current period cash flow changes
373.59%4.96M
35.48%-753.00K
140.65%276.00K
24.35%-1.08M
-371.17%-1.81M
-237.25%-1.17M
-196.37%-679.00K
-66937.69%-1.43M
-357.63%-385.00K
--850.30K
--704.55K
--2.14K
--149.44K
Effect of exchange rate changes
82.14%-10.00K
-111.70%-11.00K
137.88%25.00K
93.14%-19.00K
-394.74%-56.00K
--94.00K
---66.00K
---277.00K
--19.00K
----
----
----
----
Ending cash balance
120.17%6.23M
-72.66%1.27M
-65.19%2.02M
-73.09%1.75M
-64.27%2.83M
-96.02%4.64M
-94.99%5.81M
-94.37%6.49M
-93.12%7.92M
--116.75M
--115.90M
--115.20M
--115.19M
Free cash flow
-39.87%-2.46M
-132.04%-2.93M
-286.25%-2.67M
36.53%-1.06M
-92.97%-1.76M
---1.26M
---691.00K
---1.68M
---911.00K
----
----
----
----
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
